Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01212822
Title Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

esophageal carcinoma

gastric cardia carcinoma

gastroesophageal junction adenocarcinoma

Therapies

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497 United States Details
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field